Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
27.11 USD +5.12% Intraday chart for Protagonist Therapeutics, Inc. +6.06% +18.23%
May. 07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Revisions Protagonist Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW